The first radical prostate cancer operation in Dubai with preservation of sexual potency.
Semir A. S. Al Samarrai
With the advent of prostate specific antigen (PSA) screening and increased public awareness of the prostatic cancer because of the dramatically increased incidence of this cancer during the last decade, although this incidence has leveled off, approximately 200.000 new cases are diagnosed annually in the United States, the earlier diagnosis of the prostate cancer through the advent of the prostate specific antigen (PSA) and transrectal prostate ultrasound (TRPUS) screening programs a stage migration of the cancer toward to earlier stage has allowed radical organ confined and local operation of this cancer with curative intent.
Currently the Uro-surgeon prof.Semir Ahmed Al-Samarrai performed with success the radical removal a prostate cancer with a PSA of 102.70 ng/ml before the operation and only 1.77ng/ml after this operation (reference Range0.0-4.0ng/ml).The patient left the hospital after five days without any complications.
The technique which prof.Al-Samarrai used (NSRRP)(Nerve-sparing radical retropubic prostatectomy) represent the curative method of choice for treating localized prostate cancer internationally and aiming an optimal oncological control, optimal staging by pelvic lymph node dissection of the primary lymphatics , preservation of continence ,sexual potency and minimal surgery-associated morbidity.
Prof. Dr. SEMIR AHMED SALIM AL SAMARRAI
Professor Doctor of Medicine-Urosurgery, Andrology, and Male Infertility
Dubai Healthcare City, Dubai, United Arab Emirates.
Mailing Address: Dubai Healthcare City, Bldg. No. 64, Al Razi building, Block D,
2nd floor, Dubai, United Arab Emirates, PO box 13576